In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Takeda pays $60mm to buy LigoCyte and norovirus vaccine

Executive Summary

Takeda Pharmaceutical Co. Ltd. and its US holding company Takeda America Holdings Inc. will pay $60mm in cash up front plus undisclosed development-based earn-outs to buy LigoCyte Pharmaceuticals Inc., a privately owned company that is developing vaccines for infectious and respiratory diseases.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Cash
    • Includes Earnout
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register